HomeNWRN • SWX
add
Newron Pharmaceuticals SpA
Previous close
CHF 9.22
Day range
CHF 9.07 - CHF 9.34
Year range
CHF 6.10 - CHF 11.45
Market cap
177.18M CHF
Avg Volume
91.72K
P/E ratio
-
Dividend yield
-
Primary exchange
SWX
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 1.70M | -37.99% |
Operating expense | 5.54M | 13.16% |
Net income | -4.78M | -37.51% |
Net profit margin | -280.51 | -121.75% |
Earnings per share | — | — |
EBITDA | -3.79M | -80.47% |
Effective tax rate | -0.14% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 12.19M | -28.89% |
Total assets | 24.94M | -20.82% |
Total liabilities | 55.77M | 6.32% |
Total equity | -30.83M | — |
Shares outstanding | 19.06M | — |
Price to book | -5.69 | — |
Return on assets | -38.51% | — |
Return on capital | -53.30% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -4.78M | -37.51% |
Cash from operations | -4.41M | -57.56% |
Cash from investing | 1.00M | 18,363.64% |
Cash from financing | 4.19M | 8,737.11% |
Net change in cash | 779.50K | 127.30% |
Free cash flow | -2.95M | -55.06% |
About
CEO
Founded
1999
Website
Employees
22
